Aloe Blacc’s fame means nothing in biotech (and that’s the point)
When Grammy-nominated singer-songwriter Aloe Blacc got COVID despite being vaccinated and boosted, he tried to fund research for a better solution. What he quickly found out? You can’t just write a check in biotech. Regulators require a commercialization plan, and philant...
Signal weather
Stable
The story has moved beyond the first headline and now acts as a reliable context anchor.
When Grammy-nominated singer-songwriter Aloe Blacc got COVID despite being vaccinated and boosted, he tried to fund research for a better solution. What he quickly found out? You can’t just write a check in biotech. Regulators require a commercialization plan, and philanthropy doesn’t move science through clinical trials or get you a license on university IP. Now, he’s bootstrapping a cancer drug platform targeting pancreatic cancer, a disease that […]
Stay on the signal
Follow Aloe Blacc’s fame means nothing in biotech (and that’s the point)
Follow this story beyond a single article: new follow-ups, adjacent sources, and the evolving storyline.
Story map
Understand this topic fast
A quick entry into the story: why it matters now, who is involved, and where to go next for context.
Why it matters now
Topic constellation
Open the live map for this story
See which entities, story threads, sources, and follow-up articles shape this story right now.
Click nodes to continue
Entity pages
Story timeline
Continue with this story
A short sequence of events and follow-up stories to understand the arc quickly.
How reliable this looks
Signal and trust for TechCrunch
This source works at a rapid pace: 100% of recent stories land in the hot window, and 0% carry visible search signal.
Reliability
92
Freshness
100
Sources in storyline
1
Related articles
More stories that share tags, source, or category context.
The Trump administration might take an equity stake in OpenAI
President Donald Trump said he's discussing deals "where the American people can benefit from the success of AI."
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
Beyond Instagram: Introducing the next generation of social apps
These newer social apps offer alternatives to Big Tech’s feeds, focusing on interests, creativity, and community.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
Founders share VC horror stories, and some are naming names
A massive viral conversation sharing VC horror stories has taken place this week on X. Some are weird. Some are infuriating.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
Former cyber executive turned whistleblower accuses IBM of covering up several data breaches
IBM and two of its subsidiary companies were allegedly breached during the mid-2010s — a lawsuit filed by a former cybersecurity executive accuses IBM of not disclosing and acti...
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
More from TechCrunch
Fresh reporting and follow-up coverage from the same newsroom.
The Trump administration might take an equity stake in OpenAI
President Donald Trump said he's discussing deals "where the American people can benefit from the success of AI."
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
Beyond Instagram: Introducing the next generation of social apps
These newer social apps offer alternatives to Big Tech’s feeds, focusing on interests, creativity, and community.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
Reid Hoffman is leaving Microsoft’s board to go ‘founder mode’ with startup Manus
After a very profitable decade on Microsoft's board, Reid Hoffman is stepping down to focus on his AI drug discovery startup Manus.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
Founders share VC horror stories, and some are naming names
A massive viral conversation sharing VC horror stories has taken place this week on X. Some are weird. Some are infuriating.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.